Am J Transplant, Volume 17, Suppl 3 Archives - Page 181 of 181 - ATC Abstracts

2017 American Transplant Congress
Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.
M. Barry,¹ M. Gupta,² D. Goldberg,³ M. Levine,² D. Simpson,² K. Olthoff,² A. Shaked,² P. Abt.²
¹School of Medicine, University of Pennsylvania, Philadelphia, PA; ²Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; ³Medicine, Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA
Introduction: Retransplantation with a third liver allograft is controversial with significant technical and medical challenges. National outcomes have not been described. We hypothesize that prior…
2017 American Transplant Congress
Surgical Outcomes of Pair-Watch Suturing Technique (PWST) for Duct-To-Duct Biliary Anastomosis in an Attempt to Reduce the Biliary Complications in Living Donor Liver Transplantation.
A. Tanemura, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji.
Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Japan
Objectives:Biliary stricture is one of the major complications after living donor liver transplantation (LDLT) with duct-to-duct biliary reconstruction. To prevent biliary stenosis, we have adopted…
2017 American Transplant Congress
Eliminating False Positive Virtual Crossmatch Results for Lung Transplant Candidates by Using Multiple Antibody Testing Platforms.
O. Timofeeva,¹ M. Kashem,² S. Geier,¹ D. Grogan,² S. Keshavamurthy,² J. Gomez-Abraham,² Y. Toyoda,² F. Cordova.²
¹Department of Pathology and Laboratory of Medicine, Temple University, Lewis Katz School of Medicine, Philadelphia, PA; ²Department of Cardiovascular Surgery, Temple University, Lewis Katz School of Medicine, Philadelphia, PA
Purpose: At present, immunologic risk for lung transplant patients is evaluated based on Virtual crossmatch (VXM) by comparing recipient's HLA antibodies detected by Single antigen…
2017 American Transplant Congress
Echinocandins in Lung Transplant Recipients (LTRs).
Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹
¹Transplant Infectious Diseases, University Health Network, Toronto, ON, Canada; ²Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada
Purpose: Echinocandins are a class of antifungal drugs that have activity against Aspergillus species. However, the use of echinocandins in LTRs is not well reported.…
2017 American Transplant Congress
Transcatheter Relief of Symptomatic Hepatic Venous Outflow Obstruction Following Pediatric Liver Transplantation.
B. Goldstein, G. Tiao, M. Alonso, N. Johnson, J. Heubi, K. Averin, J. Bucuvalas.
Cincinnati Children's Hospital, Cincinnati, OH
Background: Technical-variant allograft (TVA) pediatric liver transplantation (LT) is associated with vascular complications. Early recognition and treatment of hepatic venous outflow obstruction (HVOO) may be…
2017 American Transplant Congress
The Effect of Low-Dose IL-2 in Clinical Facial Transplantation: Molecular and Immunological Response.
N. Murakami,¹ T. Win,¹ T. Borges,¹ C. Lian,¹ G. Murphy,¹ E. Bueno,¹ R. Clark,¹ T. Strom,² B. Pomahac,¹ L. Riella.¹
¹Brigham and Women's Hospital, Boston; ²Beth Israel Deaconess Medical Center, Boston
BackgroundRegulatory T cells (Tregs) play a critical role in immune tolerance and low-dose recombinant IL-2 administration has been reported to expand Tregs in vivo. Although…